top of page

Foreign Speakers

Espen

2018.5-present

Roche Medical & Scientific Affairs Manager, Oncology, Singapore

2016.4-2018.5

Roche Medical Affairs Director, Tucson, Arizona Area

2013.10-2016.4

Roche Senior Scientist, Tucson, Arizona Area

Developing and investigating IVD products in molecular diagnostics, he gained an understanding of the capacities and limitations of biomarkers. Now, applying that knowledge to support oncologists and medical colleagues can help drive personalized health care and the role of diagnostic panels in patient care.

Mr. Walker have developed and implemented medical strategy plans for several disease states, including the breast diagnostics portfolio and PD-L1 indications for lung and bladder.

Interacting with clinicians, Mr. Walker  have developed clinical studies, held advisory boards, ran speaker engagements, and coordinated many publications. 

Mr. Walker ‘s strong background in oncology research has served me well to help build relationships with clinicians in both pathology and oncology. During his postdoctoral training at University of California, San Francisco, Mr. Walker developed a genetic mouse tumor model and conducted clinical research.

Nicolas

Dr. Martin is an experienced medical affairs professional who has worked in various therapeutic area including immunology, oncology and haematology.

His current role focuses on precision medicine in oncology and haematology.

What Dr. Martin enjoy the most about working in medical affairs is the scientific challenges, the leadership of a medical affairs portfolio and the strong cross functional work.

Prior to joining the pharmaceutical industry, Dr. Martin have spent 7 years in medical research as an epidemiologist and geneticist. During that time, Dr. Martin have worked on large scale epidemiological projects that have investigated the aetiology of diseases and quantitative traits. His work has been published in high impact factor journals.

Dr. Martin driven by the desire to learn new skills and develop his knowledge in different therapeutic areas.

Laura

PROFESSIONAL SUMMARY

Epidemiologist with over 10 years of real-world data/observational research and project management experience in the pharmaceutical industry. Strong skills in observational research methods, safety epidemiology and medical communication to both technical and non-technical audiences. 

Ability to think strategically, work effectively with cross-functional teams and interact with different levels of management.Excellent relationship management and project management skills.

PROFESSIONAL EXPERIENCE

EDUCATION

Genentech, Incorporated, South San Francisco, CA

Master of Public Health, Epidemiology, Graduate School of Public Health, San Diego State University, San Diego, California, May 2005

Thesis: The Relationship between Family History and Dietary Change among a Cohort of At-Risk San Diego WomenBachelor of Science, Molecular Biology, University of California, San Diego, San Diego, California, June 1997

主辦單位│中華民國癌症醫學會​、羅氏大藥廠

本網站目的在供台灣醫護人員使用。本平台原非用於通報不良事件(副作用),但您可透過網站,向台灣羅氏藥品安全部門通報不良事件,或前往全國藥物不良反應系統網站進行通報。

請注意:網站內容包含羅氏產品的相關資訊皆有相關產品許可證,但也包含目前尚未在台灣取得許可證、非羅氏產品的數據資訊,以及在其許可適應症範圍之外使用的非羅氏藥物 ,若您需要了解更多非羅氏產品的更多訊息,請聯繫相關製造商。

bottom of page